HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Renée Bazin Selected Research

Intravenous Immunoglobulins (IVIG)

2/2014Intravenous immunoglobulin modulates the expansion and cytotoxicity of CD8+ T cells.
1/2014IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.
12/2013Brain bioavailability of human intravenous immunoglobulin and its transport through the murine blood-brain barrier.
8/2013Cationized IVIg as a potential substitute to IVIg for the treatment of experimental immune thrombocytopenia.
2/2013Immunoglobulin G dimers and immune complexes are dispensable for the therapeutic efficacy of intravenous immune globulin in murine immune thrombocytopenia.
1/2012Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's disease.
12/2011Prevention of T cell activation by interference of internalized intravenous immunoglobulin (IVIg) with MHC II-dependent native antigen presentation.
3/2010Indirect inhibition of in vivo and in vitro T-cell responses by intravenous immunoglobulins due to impaired antigen presentation.
10/2009Activation of cryptic IgG reactive with BAFF, amyloid beta peptide and GM-CSF during the industrial fractionation of human plasma into therapeutic intravenous immunoglobulins.
10/2007Picogram doses of lipopolysaccharide exacerbate antibody-mediated thrombocytopenia and reduce the therapeutic efficacy of intravenous immunoglobulin in mice.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Renée Bazin Research Topics

Disease

7Autoimmune Diseases (Autoimmune Disease)
02/2014 - 10/2004
5Thrombocytopenia (Thrombopenia)
08/2013 - 10/2006
3Thrombocytopenic Purpura (Thrombopenic Purpura)
10/2007 - 10/2006
2Graft vs Host Disease (Graft-Versus-Host Disease)
06/2015 - 09/2014
2Alzheimer Disease (Alzheimer's Disease)
01/2014 - 12/2013
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
05/2005 - 10/2004
1Memory Disorders (Memory Loss)
01/2014
1Parkinson Disease (Parkinson's Disease)
01/2012
1Hypersensitivity (Allergy)
10/2009
1Infection
10/2007
1Bacterial Infections (Bacterial Infection)
10/2007

Drug/Important Bio-Agent (IBA)

15Intravenous Immunoglobulins (IVIG)FDA Link
02/2014 - 10/2004
6Immunoglobulins (Immunoglobulin)IBA
02/2014 - 03/2007
5Immunoglobulin G (IgG)IBA
02/2013 - 05/2005
5Inosine Triphosphate (ITP)IBA
02/2013 - 10/2004
2Antigen-Antibody Complex (Immune Complex)IBA
02/2013 - 10/2006
2AntibodiesIBA
10/2007 - 03/2007
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2012
1AntigensIBA
12/2011
1Interferon-gamma (Interferon, gamma)IBA
10/2007
1Rho(D) Immune Globulin (RhoGAM)IBA
03/2007
1CytokinesIBA
03/2007
1AutoantibodiesIBA
05/2005

Therapy/Procedure

2Homologous Transplantation (Allograft)
06/2015 - 09/2014
1Transplantation (Transplant Recipients)
06/2015
1Stem Cell Transplantation
09/2014
1Immunotherapy
01/2012